An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

Researchers from the University at Buffalo and Roswell Park Comprehensive Cancer Center are developing an artificial ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths—around 1.8 million lives lost each year. One of the main reasons is late ...

DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...

Rectal cancer deaths among millennials under 45 are rising 2–3 times faster than colon cancer. Doctors urge early symptom ...

Researchers are advancing AI’s role in healthcare by integrating human-relevant preclinical models with computational frameworks to improve cancer immunotherapy predictions, while also expanding AI’s ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year. One of the main reasons is late ...

At AACR, Guardant Health and a Japanese group showcased data on machine learning models that predict the tissue of origin in cancers of unknown primary.

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.